253 related articles for article (PubMed ID: 11101551)
1. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
Stigum H; Magnus P; Samdal HH; Nord E
Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551
[TBL] [Abstract][Full Text] [Related]
2. [HTLV examination of Norwegian blood donors].
Samdal HH; Skaug K; Stigum H; Hervig T; Kjeldsen-Kragh J; Skar AG
Tidsskr Nor Laegeforen; 1999 Jan; 119(2):206-8. PubMed ID: 10081351
[TBL] [Abstract][Full Text] [Related]
3. [Quality adjusted life years in assessment of preventive measures. Should blood donors be tested for HTLV-I/II infections?].
Magnus P; Stigum H; Nord E; Bjørndal A; Samdal HH; Skulberg A; Heier HE
Tidsskr Nor Laegeforen; 1996 Apr; 116(10):1229-32. PubMed ID: 8658396
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
5. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus type I and II in transfusion medicine.
Sandler SG; Fang CT; Williams AE
Transfus Med Rev; 1991 Apr; 5(2):93-107. PubMed ID: 1687974
[TBL] [Abstract][Full Text] [Related]
8. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
9. Human T-lymphotropic virus and transfusion safety: does one size fit all?
Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Piccinini V; Liumbruno GM; Grazzini G
Transfusion; 2016 Jan; 56(1):249-60. PubMed ID: 26388300
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.
Lu SC; Kao CL; Chin LT; Chen JW; Yang CM; Chang JH; Hsu SC; Chang AC; Chen BH
Int J Hematol; 2001 Oct; 74(3):333-7. PubMed ID: 11721972
[TBL] [Abstract][Full Text] [Related]
11. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.
Lee HH; Swanson P; Rosenblatt JD; Chen IS; Sherwood WC; Smith DE; Tegtmeier GE; Fernando LP; Fang CT; Osame M
Lancet; 1991 Jun; 337(8755):1435-9. PubMed ID: 1675317
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network.
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):68-77. PubMed ID: 8797688
[TBL] [Abstract][Full Text] [Related]
13. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up.
Pinto MT; Rodrigues ES; Malta TM; Azevedo R; Takayanagui OM; Valente VB; Ubiali EM; Covas DT; Kashima S
Rev Inst Med Trop Sao Paulo; 2012; 54(3):123-9. PubMed ID: 22634882
[TBL] [Abstract][Full Text] [Related]
15. Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations.
Hindawi S; Badawi M; Fouda F; Mallah B; Mallah B; Rajab H; Madani TA
Transfus Med; 2018 Feb; 28(1):60-64. PubMed ID: 28656665
[TBL] [Abstract][Full Text] [Related]
16. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
17. HTLV-I/II prevalence in different geographic locations.
Vrielink H; Reesink HW
Transfus Med Rev; 2004 Jan; 18(1):46-57. PubMed ID: 14689377
[TBL] [Abstract][Full Text] [Related]
18. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
Lee YH; Lu CT; Feng IJ; Hung CM
Transfus Med; 2023 Aug; 33(4):320-328. PubMed ID: 37209036
[TBL] [Abstract][Full Text] [Related]
19. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
Donegan E; Lee H; Operskalski EA; Shaw GM; Kleinman SH; Busch MP; Stevens CE; Schiff ER; Nowicki MJ; Hollingsworth CG
Transfusion; 1994 Jun; 34(6):478-83. PubMed ID: 8023388
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)].
Colin DD; Alcântara Júnior LC; Santos FL; Uchôa R; Tavares-Neto J
Rev Soc Bras Med Trop; 2003; 36(6):677-83. PubMed ID: 15049106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
